The Centers for Medicare and Medicaid Services (CMS) say that the first-ever cancer vaccine, sipuleucel-T (Provenge) from Dendreon would be covered for FDA-approved usages of the treatment.
Women over 50 years old with early breast cancer confined to one breast who took 20 mg of tamoxifen daily for 5 years were less likely to relapse than those who took the drug for 2 years.
The Journal of Clinical Oncology published a paper ahead of print on March 21, 2011 that shows no increased risk of venous thromboembolisms (VTEs) when bevacizumab was added to chemotherapy compared to chemotherapy alone.
The National Comprehensive Cancer Network presented the first treatment algorithm for post-transplant lymphoproliferative disorder (PTLD) at the 16th annual NCCN's Conference on Clinical Practice Guidelines and Quality.
Body mass index (BMI), waist circumference, and waist-to-hip ratio all have a similar strength of association with cardiovascular disease, but do not significantly improve risk prediction when information on blood pressure, diabetes, and lipid levels is available, according to a study published online March 11 in The Lancet.
As we learn more about the network of cellular pathways that function in the proliferation of cancer cells, it is becoming abundantly clear that there is no “magic bullet” cancer treatment. Janet Woodcock highlights the goals and current developments at the FDA to progress the combination clinical trial process
Researchers at the University of Milan sought to assess the clinical relevance of biopsying primary breast cancers and secondary metastatic liver lesions to evaluate the occurrence of important markers.
The American Society of Clinical Oncology (ASCO) updated its recommendation last month on the role of bone-modifying agents in the prevention of skeletal-related events (SREs) for metastatic breast cancer patients with bone metastases.
There is a lack of sex-specific data relating to the safety and effectiveness of high-risk cardiovascular devices prior to U.S. Food and Drug Administration approval, according to a review published online March 1 in Circulation: Cardiovascular Quality and Outcomes.
Health care professionals can play a big role in helping overweight patients lose weight and maintain weight loss, starting with acknowledging their overweight status in the first place, according to two studies published in the Feb. 28 issue of the Archives of Internal Medicine.